Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Showing 1 - 20 of 102 Results

Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Clinical Coordinating Center (Collaborative UG3/UH3 Clinical Trial Required)

Release Date
Expiration Date
Expiration Date
Type of Award
Clinical Trials
Organizations
Archived
Yes

Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional)

Release Date
Expiration Date
Expiration Date
Type of Award
Clinical Trials
Organizations
Archived
Yes

Notice of Special Interest (NOSI): Interventions to Reduce Chronic Inflammation and Inflammation-Related Morbidity in People Living with HIV/AIDS

Release Date
Expiration Date
Expiration Date
Type of Award
Clinical Trials
Organizations
Archived
Yes

Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral Research

Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)

Notice of Special Interest (NOSI): Firearm Injury and Mortality Prevention Research

Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Required)

Release Date
Expiration Date
Expiration Date
Supporting Information:
Type of Award
Clinical Trials
Organizations
Archived
Yes

Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required)

Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions